Literature DB >> 16013442

5' diversity of human hepatic PXR (NR1I2) transcripts and identification of the major transcription initiation site.

Kouichi Kurose1, Satoru Koyano, Shinobu Ikeda, Masahiro Tohkin, Ryuichi Hasegawa, Jun-Ichi Sawada.   

Abstract

The human pregnane X receptor (PXR) is a crucial regulator of the genes encoding several major cytochrome P450 enzymes and transporters, such as CYP3A4 and MDR1, but its own transcriptional regulation remains unclear. To elucidate the transcriptional mechanisms of human PXR gene, we first endeavored to identify the transcription initiation site of human PXR using 5'-RACE. Five types of 5'-variable transcripts (a, b, c, d, and e) with common exon 2 sequence were found, and comparison of these sequences with the genomic sequence suggested that their 5' diversity is derived from initiation by alternative promoters and alternative splicing. None of the exons found in our study contain any new in-frame coding regions. Newly identified introns IVS-a and IVS-b were found to have CT-AC splice sites that do not follow the GT-AG rule of conventional donor and acceptor splice sites. Of the five types of 5' variable transcripts identified, RT-PCR showed that type-a was the major transcript type. Four transcription initiation sites (A-D) for type-a transcript were identified by 5'-RACE using GeneRacer RACE Ready cDNA (human liver) constructed by the oligo-capping method. Putative TATA boxes were located approximately 30 bp upstream from the transcriptional start sites of the major transcript (C) and the longest minor transcript (A) expressed in the human liver. These results indicate that the initiation of transcription of human PXR is more complex than previously reported.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16013442     DOI: 10.1007/s11010-005-7757-7

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  23 in total

1.  Orphan receptor promiscuity in the induction of cytochromes p450 by xenobiotics.

Authors:  D Smirlis; R Muangmoonchai; M Edwards; I R Phillips; E A Shephard
Journal:  J Biol Chem       Date:  2001-01-24       Impact factor: 5.157

2.  Identification of the novel splicing variants for the hPXR in human livers.

Authors:  Shuichi Fukuen; Tsuyoshi Fukuda; Hideyasu Matsuda; Akihiko Sumida; Isamu Yamamoto; Tadanobu Inaba; Junichi Azuma
Journal:  Biochem Biophys Res Commun       Date:  2002-11-01       Impact factor: 3.575

3.  Regulation of the human CYP2B6 gene by the nuclear pregnane X receptor.

Authors:  B Goodwin; L B Moore; C M Stoltz; D D McKee; S A Kliewer
Journal:  Mol Pharmacol       Date:  2001-09       Impact factor: 4.436

4.  Reciprocal activation of xenobiotic response genes by nuclear receptors SXR/PXR and CAR.

Authors:  W Xie; J L Barwick; C M Simon; A M Pierce; S Safe; B Blumberg; P S Guzelian; R M Evans
Journal:  Genes Dev       Date:  2000-12-01       Impact factor: 11.361

5.  Novel, nonconsensus cellular splicing regulates expression of a gene encoding a chemokine-like protein that shows high variation and is specific for human herpesvirus 6.

Authors:  C French; P Menegazzi; L Nicholson; H Macaulay; D DiLuca; U A Gompels
Journal:  Virology       Date:  1999-09-15       Impact factor: 3.616

Review 6.  Evaluation of the toxicological relevance of CYP3A4 induction.

Authors:  Nick J Plant; G Gordon Gibson
Journal:  Curr Opin Drug Discov Devel       Date:  2003-01

7.  Control of steroid, heme, and carcinogen metabolism by nuclear pregnane X receptor and constitutive androstane receptor.

Authors:  Wen Xie; Mei-Fei Yeuh; Anna Radominska-Pandya; Simrat P S Saini; Yoichi Negishi; Bobbie Sue Bottroff; Geraldine Y Cabrera; Robert H Tukey; Ronald M Evans
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-18       Impact factor: 11.205

8.  Natural protein variants of pregnane X receptor with altered transactivation activity toward CYP3A4.

Authors:  E Hustert; A Zibat; E Presecan-Siedel; R Eiselt; R Mueller; C Fuss; I Brehm; U Brinkmann; M Eichelbaum; L Wojnowski; O Burk
Journal:  Drug Metab Dispos       Date:  2001-11       Impact factor: 3.922

9.  Analysis of the role of Caenorhabditis elegans GC-AG introns in regulated splicing.

Authors:  Tracy Farrer; A Brock Roller; W James Kent; Alan M Zahler
Journal:  Nucleic Acids Res       Date:  2002-08-01       Impact factor: 16.971

10.  Identification of a human nuclear receptor defines a new signaling pathway for CYP3A induction.

Authors:  G Bertilsson; J Heidrich; K Svensson; M Asman; L Jendeberg; M Sydow-Bäckman; R Ohlsson; H Postlind; P Blomquist; A Berkenstam
Journal:  Proc Natl Acad Sci U S A       Date:  1998-10-13       Impact factor: 11.205

View more
  6 in total

1.  Identification of regulatory sites in the human PXR (NR1I2) promoter region.

Authors:  Kouichi Kurose; Shinobu Ikeda; Satoru Koyano; Masahiro Tohkin; Ryuichi Hasegawa; Jun-ichi Sawada
Journal:  Mol Cell Biochem       Date:  2006-01       Impact factor: 3.396

Review 2.  Transcriptional and post-transcriptional regulation of the pregnane X receptor: a rationale for interindividual variability in drug metabolism.

Authors:  Tomas Smutny; Lucie Hyrsova; Albert Braeuning; Magnus Ingelman-Sundberg; Petr Pavek
Journal:  Arch Toxicol       Date:  2020-11-09       Impact factor: 5.153

3.  Comparative genomics of xenobiotic metabolism: a porcine-human PXR gene comparison.

Authors:  Callie B Pollock; Margarita B Rogatcheva; Lawrence B Schook
Journal:  Mamm Genome       Date:  2007-04-15       Impact factor: 2.957

4.  Suppression of the pregnane X receptor during endoplasmic reticulum stress is achieved by down-regulating hepatocyte nuclear factor-4α and up-regulating liver-enriched inhibitory protein.

Authors:  Thaveechai Vachirayonsti; Karen W Ho; Dongfang Yang; Bingfang Yan
Journal:  Toxicol Sci       Date:  2015-01-22       Impact factor: 4.849

5.  Involvement of promoter methylation in the regulation of Pregnane X receptor in colon cancer cells.

Authors:  Wataru Habano; Toshie Gamo; Jun Terashima; Tamotsu Sugai; Koki Otsuka; Go Wakabayashi; Shogo Ozawa
Journal:  BMC Cancer       Date:  2011-02-22       Impact factor: 4.430

Review 6.  PXR variants: the impact on drug metabolism and therapeutic responses.

Authors:  C Trent Brewer; Taosheng Chen
Journal:  Acta Pharm Sin B       Date:  2016-07-27       Impact factor: 11.413

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.